Retatrutide often called Reta in online communities is the next-generation weight loss peptide currently being studied by Eli Lilly
Critics, meanwhile, say radical uptake of GLP-1 drugs for weight loss would be far too costly on the healthcare system
Lack of definitive outcomes: Many studies focus on surrogate biomarkers (GSH/GSSG, oxidative stress markers) rather than clinically meaningful endpoints
Knowing what not to do is the other half
Several pharmaceutical companies are actively exploring future opportunities in this space
BPC-157 A stable gastric pentadecapeptide derived from human body protection compound, extensively researched for its regenerative properties across multiple tissue types including tendons, muscles, the gastrointestinal tract, and the nervous system